Stock comparison
AMGEN INC is 2.4x more valuable than Moderna, Inc. by market capitalization ($249.37 B vs $105.32 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AMGN is larger
AMGEN INC is 2.4x more valuable than Moderna, Inc. by market capitalization ($249.37 B vs $105.32 B).
Market value leader
AMGN
AMGEN INC is 2.4x more valuable than Moderna, Inc. by market capitalization ($249.37 B vs $105.32 B).
Revenue leader
AMGN
MRNA: $1.94B vs AMGN: $36.75B.
Profit leader
AMGN
MRNA: -$2.82B vs AMGN: $7.71B.
Margin leader
AMGN
MRNA: -145.2% vs AMGN: 21.0% net margin.
| Metric | MRNA | AMGN |
|---|---|---|
| Market cap | $105.32 B | $249.37 B |
| US-listed rank | #145 | #55 |
| Revenue (latest FY) | $1.94B | $36.75B |
| Net income (latest FY) | -$2.82B | $7.71B |
| Net margin | -145.2% | 21.0% |
| P/E (trailing FY) | - | 32.3x |
| SEC filings | 1,447 | 1,011 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AMGEN INC is 2.4x more valuable than Moderna, Inc. by market capitalization ($249.37 B vs $105.32 B).
In their latest fiscal years, Moderna, Inc. reported $1.94B in revenue while AMGEN INC reported $36.75B.
Full pages: Moderna, Inc. and AMGEN INC, or browse the full rankings.